269 related articles for article (PubMed ID: 27077924)
1. The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy.
Subash M; Comyn O; Samy A; Qatarneh D; Antonakis S; Mehat M; Tee J; Mansour T; Xing W; Bunce C; Viswanathan A; Rubin G; Weleber R; Peto T; Wickham L; Michaelides M
JAMA Ophthalmol; 2016 Jun; 134(6):666-72. PubMed ID: 27077924
[TBL] [Abstract][Full Text] [Related]
2. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW
Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533
[TBL] [Abstract][Full Text] [Related]
3. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
[TBL] [Abstract][Full Text] [Related]
5. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
Arch Ophthalmol; 2010 May; 128(5):525-33. PubMed ID: 20457972
[TBL] [Abstract][Full Text] [Related]
6. Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.
Gabrielle PH; Massin P; Kodjikian L; Erginay A; Pallot C; Jonval L; Soudry A; Couturier A; Vardanian-Vartin C; Bron AM; Creuzot-Garcher C
Acta Ophthalmol; 2019 Aug; 97(5):e680-e687. PubMed ID: 30561087
[TBL] [Abstract][Full Text] [Related]
7. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.
Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
Acta Ophthalmol; 2013 May; 91(3):251-8. PubMed ID: 22176513
[TBL] [Abstract][Full Text] [Related]
8. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.
Messias K; Barroso RM; Jorge R; Messias A
Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775
[TBL] [Abstract][Full Text] [Related]
9. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
10. Peripheral capillary non-perfusion in treatment-naïve proliferative diabetic retinopathy associates with postoperative disease activity 6 months after panretinal photocoagulation.
Torp TL; Kawasaki R; Wong TY; Peto T; Grauslund J
Br J Ophthalmol; 2019 Jun; 103(6):816-820. PubMed ID: 30068515
[TBL] [Abstract][Full Text] [Related]
11. Effects of focal/grid laser treatment on the central visual field in diabetic macular oedema: a 2-year follow-up study.
Tababat-Khani P; Bengtsson B; Agardh E
Acta Ophthalmol; 2016 May; 94(3):240-5. PubMed ID: 26806322
[TBL] [Abstract][Full Text] [Related]
12. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
[TBL] [Abstract][Full Text] [Related]
13. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study.
Muqit MM; Young LB; McKenzie R; John B; Marcellino GR; Henson DB; Turner GS; Stanga PE
Br J Ophthalmol; 2013 Feb; 97(2):220-7. PubMed ID: 23178855
[TBL] [Abstract][Full Text] [Related]
14. Temporal changes in retinal vascular parameters associated with successful panretinal photocoagulation in proliferative diabetic retinopathy: A prospective clinical interventional study.
Torp TL; Kawasaki R; Wong TY; Peto T; Grauslund J
Acta Ophthalmol; 2018 Jun; 96(4):405-410. PubMed ID: 29193789
[TBL] [Abstract][Full Text] [Related]
15. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
16. Automated perimetric changes following panretinal photocoagulation in diabetic retinopathy.
Khosla PK; Gupta V; Tewari HK; Kumar A
Ophthalmic Surg; 1993 Apr; 24(4):256-61. PubMed ID: 8321507
[TBL] [Abstract][Full Text] [Related]
17. Spatial changes of central field loss in diabetic retinopathy after laser.
Wang Y; Muqit MM; Stanga PE; Young LB; Henson DB
Optom Vis Sci; 2014 Jan; 91(1):111-20. PubMed ID: 24366435
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Wide-Field Swept-Source OCT Angiography of Neovascularization in Proliferative Diabetic Retinopathy after Panretinal Photocoagulation.
Russell JF; Shi Y; Hinkle JW; Scott NL; Fan KC; Lyu C; Gregori G; Rosenfeld PJ
Ophthalmol Retina; 2019 Apr; 3(4):350-361. PubMed ID: 31014688
[TBL] [Abstract][Full Text] [Related]
19. Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Hutton DW; Stein JD; Glassman AR; Bressler NM; Jampol LM; Sun JK;
JAMA Ophthalmol; 2019 Dec; 137(12):1424-1432. PubMed ID: 31647496
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
